Cargando…
Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial
BACKGROUND: Treatment of acute respiratory distress syndrome (ARDS) associated with COronaVIrus Disease-2019 (COVID-19) currently relies on dexamethasone and supportive mechanical ventilation, and remains associated with high mortality. Given their ability to limit inflammation, induce immune cells...
Autores principales: | Grégoire, Céline, Layios, Nathalie, Lambermont, Bernard, Lechanteur, Chantal, Briquet, Alexandra, Bettonville, Virginie, Baudoux, Etienne, Thys, Marie, Dardenne, Nadia, Misset, Benoît, Beguin, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291273/ https://www.ncbi.nlm.nih.gov/pubmed/35860245 http://dx.doi.org/10.3389/fimmu.2022.932360 |
Ejemplares similares
-
MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process
por: Lechanteur, Chantal, et al.
Publicado: (2021) -
Clinical-scale expansion of mesenchymal stromal cells: a large banking experience
por: Lechanteur, Chantal, et al.
Publicado: (2016) -
Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury
por: Rowart, Pascal, et al.
Publicado: (2015) -
Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model
por: Grégoire, Céline, et al.
Publicado: (2019) -
Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis
por: Servais, Sophie, et al.
Publicado: (2023)